Evaluation of the effect of letrozole in the prevention of ovarian hyperstimulation syndrome

Phase 3

• Conditions: Hyperstimulation of ovaries.; Hyperstimulation of ovaries; N98.1

• Registration Number: IRCT20180313039085N1
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 November 2021

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 40

Inclusion Criteria

Candidate for treatment with ovarian superovulation drugs
history of one year of infertility at least
Body mass index less than 25 kg/m2
Antimullerian hormone levels higher than 5 ng/ml

Exclusion Criteria

History of any hormone therapy during the previous three months
History of allergy to letrozole and other aromatase inhibitors
History of heart disease
History of kidney disease
History of liver disease
History of endocrine diseases

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hyperstimulation of ovaries. Timepoint: Two weeks after starting treatment. Method of measurement: Mild, Moderate, Severe.